Ampio Pharmaceuticals Inc. (AMPE) Fundamentals

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.
SHARE INFORMATION
Market CapUS$ 6 230 417
Shares Outstanding15 085 792
Float15 056 002
Percent Float99,8%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -1,53
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions215
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months6 347 783
Institutional Holdings Percent17,1%
Institutional Sold Previous 3 Months28 705 188
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2,0
Insider Sold Previous 3 Months-
Insider Shares Owned4 438 704
TRADING INFO
52 Week HighUS$ 17,55
52 Week LowUS$ 0,20
52 Week High ChangeUS$ -97,56
21 Day Moving AverageUS$ 0,4221
21 Day Extended Moving AverageUS$ 0,436874
50 Day Moving AverageUS$ 0,5318
50 Day Extended Moving AverageUS$ 0,645987
200 Day Moving AverageUS$ 2,9196
200 Day Extended Moving AverageUS$ 3,9164
10 Day Average Volume185 182
20 Day Average Volume151 066
30 Day Average Volume119 506
50 Day Average Volume270 542
Alpha-0.003924
Beta1.5959
Standard Deviation0.391710
R20.046532
7 Day Price ChangeUS$ -0,0266
7 Day Percent Change-6,05%
21 Day Price ChangeUS$ -0,022
21 Day Percent Change-5,06%
30 Day Price ChangeUS$ -0,115
30 Day Percent Change-21,78%
Month to Date Price ChangeUS$ -0,115
Month to Date Percent Change-21,78%
Quarter to Date Price ChangeUS$ -0,4945
Quarter to Date Percent Change-54,49%
180 Day Price ChangeUS$ -2,33
180 Day Percent Change-84,94%
200 Day Price ChangeUS$ -2,86
200 Day Percent Change-87,38%
Year to Date Price ChangeUS$ -8,14
Year to Date Percent Change-95,17%

Ampio Pharmaceuticals Inc. (AMPE) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book0,40
Total Debt To Equity0,10
Int Coverage0,00
Current Ratio4,70
Leverage Ratio1,40
Quick Ratio4,30
Long Term Debt To Capital0,03
VALUATION MEASURES
PE Ratio-0,20
Enterprise ValueUS$ -10 218 684
Price to Sales0,00
Price to Free Cash-0,30
PE High Last 5 Years1,70
Price To Book0,40
Price To Cash Flow0,00
PE Low Last 5 Years-5,30
Price to Tangible Book0,40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-98,48
Return on Equity-130,71
Return on Capital-124,68

Ampio Pharmaceuticals Inc. (AMPE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMoss Adams LLP
CEOMichael A. Martino
Emplyoees9
Last AuditUQ
CIK0001411906
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address373 Inverness Parkway
Suite 200
Englewood, CO 80112
Websitehttps://www.ampiopharma.com
Facsimile+1 720 437-6501
Telephone+1 720 437-6500
Emailinfo@ampiopharma.com
Dernières Valeurs Consultées
AMEX
AMPE
Ampio Phar..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20221201 10:12:26